News
This weekend, observe the waxing crescent moon align with Mars and the bright star Regulus post-sunset, creating a stunning ...
2d
Pharmaceutical Technology on MSNNovartis concludes Regulus Therapeutics acquisitionThe transaction was approved by both companies' boards and includes a significant premium over recent stock prices for ...
Novartis today announced that its previously announced tender offer (the “Offer”) by Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), ...
Novartis has announced the expiration of its tender offer to acquire Regulus Therapeutics Inc., marking a significant step ...
Sanofi paid a more than 300% premium on its acquisition of Vigil Neuroscience, suggesting a fierce battle to seal the deal.
The conjunction between Mars and the bright blue star Regulus began on Monday (June 16) and will bring the two objects side ...
Regulus High Fantasy Arena Sports is an interesting-looking skirmish game, with no luck, asymmetrical teams, and a huge ...
Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...
We are excited to welcome the talented team at Regulus to Novartis as we continue to build on our pipeline in renal disease with high unmet medical need.” Farabursen is an investigational ...
Basel, June 25, 2025 – Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of ...
Basel: Novartis has announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. With the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results